Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

BACKGROUND: Albuminuria is a marker of inflammation and an independent predictor of cardiovascular morbidity and mortality. The current study evaluated whether eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation attenuates progression of albuminuria in subjects with coronary a...

Descripción completa

Detalles Bibliográficos
Autores principales: Elajami, Tarec K., Alfaddagh, Abdulhamied, Lakshminarayan, Dharshan, Soliman, Michael, Chandnani, Madhuri, Welty, Francine K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586259/
https://www.ncbi.nlm.nih.gov/pubmed/28710178
http://dx.doi.org/10.1161/JAHA.116.004740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586259/
https://www.ncbi.nlm.nih.gov/pubmed/28710178
http://dx.doi.org/10.1161/JAHA.116.004740

Ejemplares similares